Items (Details) (USD $)	3 Months Ended				9 Months Ended			12 Months Ended		62 Months Ended
	Sep. 30, 2012		Sep. 30, 2011	Mar. 31, 2011	Sep. 30, 2012		Sep. 30, 2011	Dec. 31, 2011		Sep. 30, 2012		Feb. 28, 2011	Feb. 07, 2011	Jan. 31, 2010	Nov. 25, 2009
Net income (loss)					$ 286,330		$ (266,575)			$ (4,613,212)
Depreciation and amortization							366			2,916
Common stock issued for services										150,390
Loss on extinguishment of debt - related parties	160,000			140,000						160,000
Increase (Decrease) in Accounts payable and accrued expenses - related parties					225,000		225,963			1,471,971
Increase (Decrease) in Accounts payable and accrued expenses					(25,929)		(23,464)			2,472
Increase (Decrease) in Advances from related parties					25,325		61,853
Purchase of equipment										(2,917)
Net Cash used in Investing Activities										(2,917)
Proceeds from sale of common stock										1,226,750
Proceeds from notes payable - related parties							40,100			200,000
Proceeds from Advances from related parties					62,760		23,564			714,691
Repayment of advances from related parties					(3,036)
Effect of merger adjustment										(16,596)
Net cash provided by financing activities					62,760		63,664			2,571,809
Net Increase (decrease) in cash					826		(44)			1,282
Cash At Beginning Period				560	456		560	560
Cash At End Of Period	1,282		516		1,282		516	456		1,282
Cash and cash equivalents	1,282		516		1,282		516	456		1,282
Total Assets	1,282				1,282			456		1,282
Accounts payable and accrued expenses	2,472				2,472			28,400		2,472
Accounts payable and accrued expenses - related party	275,462		94,499		275,462		94,499			275,462
Advances from related parties	333,770				333,770			243,770		333,770
Note payable - related party	396,000				396,000			396,000		396,000
Total Liabilities	2,192,950				2,192,950			1,905,794		2,192,950
Stockholders' Equity (Deficiency):	(2,191,668)				(2,191,668)			(1,905,338)		(2,191,668)
Preferred stock		[1]				[1]			[1]		[1]
Common stock	36,720	[2]			36,720	[2]		36,720	[2]	36,720	[2]
Additional paid-in capital	2,423,952				2,423,952			2,423,952		2,423,952
Deficit accumulated during the development stage	(4,652,340)				(4,652,340)			(4,366,010)		(4,652,340)
Total Stockholders' Equity (Deficiency)	(2,191,668)				(2,191,668)			(1,905,338)		(2,191,668)
Total Liabilities and Stockholders' Equity/(Deficit)	1,282				1,282			456		1,282
Common Stock, Shares, Issued												1,000,000	7,000,000	1,471,419	200,000
Net (Loss)	$ (91,475)		$ (81,978)		$ (286,330)		$ (266,575)	$ 540,350		$ (4,613,212)

[1] 5,000,000 shares authorized;$.001 par value; 1,000,000 shares issued and none outstanding

[2] 100,000,000 shares authorized; $.001 par value; 36,719,854 shares issued and outstanding at September 30, 2012; and December 31, 2011, respectively